Abstract
Mirtazapine (MTZ) is an atypical antidepressant approved by the FDA, which mechanism of action involves the antagonism of alpha-2, H1, 5-HT2A, 5-HT2C,......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
